Results 151 to 160 of about 230,556 (169)

Current concepts regarding Graves’ orbitopathy [PDF]

Journal of Internal Medicine, 2022
Graves' orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal manifestation of Graves' disease, the most common cause of hyperthyroidism.
Maria Laura Tanda, Luigi Bartalena
exaly   +2 more sources

Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study [PDF]

Journal of Endocrinological Investigation, 2020
PURPOSE: Patients with Graves' orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves' orbitopathy. METHODS: This was a multi-centre
Petros Perros, Luigi Bartalena, Michele Marinò   +2 more
exaly   +3 more sources

Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves’ orbitopathy

Japanese Journal of Ophthalmology, 2008
To compare color Doppler imaging (CDI) parameters of the superior ophthalmic vein (SOV) in patients with Graves` orbitopathy (GO) and in normal controls. Forty-three GO patients and 14 normal controls underwent CDI of the SOV.
Mario Luiz Ribeiro Monteiro
exaly   +1 more source

Lower Eyelid Contour in Graves Orbitopathy

Current Eye Research, 2019
Purpose: The aim of the present study was to analyze quantitively the lower lid contour of patients with Graves orbitopathy. Methods: Bézier curves were manually adjusted to the ciliated and nasal (or lacrimal) portions of the lower lid contour of 41 ...
Denny M Garcia
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves’ Orbitopathy

Ocular Immunology and Inflammation, 2022
Vincent Borderie, Arsène Mekinian, Azeddine Dellal   +2 more
exaly  

Polydatin attenuates orbital oxidative stress in Graves’ orbitopathy through the NRF2 pathway

Chemico-Biological Interactions, 2020
Hong Li
exaly  

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

Therapeutic Advances in Endocrinology and Metabolism, 2020
George J. Kahaly, Jan Längericht
exaly  

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Lancet, The, 2000
Caroline B Terwee, Maarten P Mourits, M P Mourits   +2 more
exaly  

Place of radiotherapy in the treatment of Graves’ orbitopathy

International Journal of Radiation Oncology Biology Physics, 1999
Pierre Bey, T Maalouf, Elisabeth Luporsi
exaly  

Late reactivation of thyroid orbitopathy

Clinical and Experimental Ophthalmology, 2004
Dinesh Selva, Dinesh Selva Franzco
exaly